RSNA: Tracking Facilitates SABR in Lung Cancer

In the first report of its kind, Japanese researchers described successful ablation of early stage lung cancers using a linear accelerator that permits real-time tracking of target tumour movement as the patient breathes. After 2 years, local control was achieved in 87% of the 29 patients who were treated using the new system of stereotactic ablation body radiation, and 2-year overall survival was 71.8%, reported Takamasa Mitsuyoshi, MD, PhD, professor of radiation oncology and image-applied therapy, at Kyoto University.
Medpage Today